Thyroid Dysfunction and Sleep Disorders

Green, Max E.; Bernet, Victor; Cheung, Joseph

doi:10.3389/fendo.2021.725829

Cited by 53 publications

(36 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hyperthyroidism (overactive) can cause difficulty sleeping due to arousals from nervousness or irritability ( 51 , 52 ). An overactive thyroid may also lead to night sweats and frequent urges to urinate, both of which can disrupt sleep ( 52 , 53 ). Similarly, studies showed hypothyroidism also linked with longer onset and shorter duration of sleep caused by difficulty of tolerating cold at night and joint or muscle pain ( 51 , 52 ).…”

Section: Discussionmentioning

confidence: 99%

Poor Sleep Quality and Factors Among Reproductive-Age Women in Southwest Ethiopia

et al. 2022

View full text Add to dashboard Cite

BackgroundAdequate sleep is vital for physical and mental wellbeing. Sleep-related problems including poor quality of sleep have been increasing throughout the world among reproductive-aged women. Poor sleep quality has been related with number of diseases and health problems However, evidences are scarce regarding poor sleep quality and its associated factors among women of the reproductive age group in Ethiopia.ObjectiveTo assess sleep quality and associated factors among women of reproductive age group in Mizan Aman town, Southwest Ethiopia.MethodCommunity-based cross-sectional study was conducted among 606 reproductive-aged women from 06 November to 20 December 2020, in Mizan Aman town. Data were collected using structured interview administered questionnaires. Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality. Multivariable logistic regression was applied using an adjusted odds ratio with a corresponding 95% confidence interval to evaluate the statistical significance of associated factors.ResultThe overall prevalence of poor sleep quality was 71.3%. The late age group of 42–49 (AOR, 95% CI; 1.21 (1.08–5.76), palpable/visible thyroid gland (AOR, 95% CI; 2. 12 (1.08–3.82), current substance use (AOR, 95% CI; 1.76 (1.11–6.10) and having premenstrual syndrome (AOR, 95% CI; 1.86 (1.38–3.12) were significantly associated with poor sleep quality among reproductive age group women.ConclusionSignificant majority of reproductive age group women faced poor sleep quality. Therefore, screening of sleep patterns among this particular age group is warranted. Moreover, education about sleep hygiene needs to be given considering the identified factors to improve sleep quality.

show abstract

Section: Discussionmentioning

confidence: 99%

Poor Sleep Quality and Factors Among Reproductive-Age Women in Southwest Ethiopia

et al. 2022

View full text Add to dashboard Cite

show abstract

“…At PO 1 month, the mean PSQI score reduced to 8.9, and further decreased to 7.8 at PO 4 months, before increasing again to 8.9 at PO 10 months. Our repeated measures of PSQI score data indicated that radioactive iodine treatment showed no harmful effect on sleep quality, although diet restriction and conditioning with severe hypothyroidism may have an unfavorable impact on sleep 39 , 40 .…”

Section: Discussionmentioning

confidence: 72%

Sleep quality of patients with papillary thyroid carcinoma: a prospective longitudinal study with 5-year follow-up

Koo

Park

Nam

et al. 2022

Sci Rep

View full text Add to dashboard Cite

We evaluated the pre- and postoperative sleep quality of patients with newly diagnosed papillary thyroid carcinoma (PTC) who underwent thyroid surgery, and investigated the factors associated with persistent poor sleep quality. The Pittsburgh sleep quality index (PSQI), Epworth sleepiness scale, and Stanford sleepiness scale were used to estimate sleep quality and daytime sleepiness. Face-to-face surveys were conducted preoperatively, and 1, 4, and 10 months after thyroid surgery. The PSQI was administered during a telephone interview about after 5 years after surgery. Forty-six patients (mean age 47.3 ± 10.1 years) with PTC (11 males, 35 females) were included in this study. Twenty-one participants underwent lobectomy and 25 underwent total thyroidectomy. Preoperatively, 35 (76.1%) patients showed poor sleep quality. PSQI scores at postoperative 1, 4, and 10 months were significantly lower than preoperative scores (p < 0.001). Postoperative 5-year PSQI scores decreased significantly compared to the preoperative scores (p < 0.001). Patients newly diagnosed with PTC suffered from sleep disturbance before and after surgery for at least 10 months, recovering to a comparable rate of sleep disturbance with the general population by 5 years after surgery. Higher preoperative PSQI score was at risk for prolonged poor sleep quality in patients with PTC.

show abstract

“…This may occur as a consequence of impaired neural response to hypoxemia and hypercapnia, increased airway resistance due to mucoprotein deposition, increase in BMI, and changes in upper airway muscle activity ( 96 ). Conversely, over-replacement may favor insomnia, increase oxygen consumption, and impact on muscle and cardiovascular function as observed in hyperthyroidism ( 98 ). Therefore, optimizing thyroxine replacement therapy may contribute to improve sleep quality and architecture in patients with CP.…”

Section: Prevention and Treatment Of Sleep Disorders In Patients With...mentioning

confidence: 99%

Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update

et al. 2022

View full text Add to dashboard Cite

Sleep disorders (SDs) represent an important issue in patients with craniopharyngioma (CP). Nearly 70% of these patients complain of sleep-wake cycle alterations and/or excessive diurnal somnolence due to sleep-related breathing disorders, such as obstructive sleep apnea (OSA) and/or central hypersomnia, including secondary narcolepsy. SDs may severely reduce quality of life, increase disease-related cardiorespiratory and cardiovascular morbidity, and finally play a major role in increased long-term mortality reported on patients with CP. A major risk factor for SDs is represented by the hypothalamic syndrome, which may develop because of direct hypothalamic damage by the tumor itself and/or complications of the treatments, neurosurgery and/or radiotherapy, and typically includes permanent neuroendocrine dysfunctions, morbid obesity, and secondary metabolic disorders. Despite increasing attention to SDs in the general population, and in particular to OSA as a risk factor for cardio-metabolic diseases and excessive daytime somnolence, sleep evaluation is still not routinely proposed to patients with CP. Hence, SDs are often underdiagnosed and undertreated. The aim of this paper is to update current knowledge of the pathogenesis and prevalence of SDs in patients with CP and propose practical algorithms for their evaluation and management in clinical practice. Particular attention is paid to screening and diagnostic tools for appropriate characterization of SDs, identification of risk factors, and potential role of hypothalamic sparing surgery in the prevention of morbid obesity and SDs. Available tools in sleep medicine, including lifestyle interventions, drugs, and respiratory devices, are discussed, as well as the importance of optimal hormone replacement and metabolic interventions. Current limits in the diagnosis and treatment of SDs in patients with CP and possible future avenues for research agenda are also considered.

show abstract

Thyroid Dysfunction and Sleep Disorders

Cited by 53 publications

References 25 publications

Poor Sleep Quality and Factors Among Reproductive-Age Women in Southwest Ethiopia

Poor Sleep Quality and Factors Among Reproductive-Age Women in Southwest Ethiopia

Sleep quality of patients with papillary thyroid carcinoma: a prospective longitudinal study with 5-year follow-up

Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update

Contact Info

Product

Resources

About